Impact of serogroup A meningococcal conjugate vaccine for Africa

References

• LaForce FM, Djingarey M, Viviani S, Preziosi MP. Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps. Hum Vaccin Immunother. 2017:0. doi: 10.1080/21645515.2017.1378841.
   PubMed Web of Science ®Google Scholar
• Dellepiane N, Akanmori BD, Gairola S, Jadhav SS, Parker C, Rodriguez C, Srivastava S. Regulatory Pathways That Facilitated Timely Registration of a New Group A Meningococcal Conjugate Vaccine for Africa's Meningitis Belt Countries. Clin Infect Dis. 2015;61(Suppl 5):S428–33. doi:10.1093/cid/civ491.
   PubMedGoogle Scholar
• Okwo-Bele JM, LaForce FM, Borrow R, Preziosi MP. Documenting the Results of a Successful Partnership: A New Meningococcal Vaccine for Africa. Clin Infect Dis. 2015;61(Suppl 5):S389–90. doi:10.1093/cid/civ592.
   PubMedGoogle Scholar
• Sambo L, Chan M, Davis S, Lake A, Berkley S, Poonawalla C, Elias CJ. A Vaccine Meets Its Promise: Success in Controlling Epidemic Meningitis in Sub-Saharan Africa. Clin Infect Dis. 2015;61(Suppl 5):S387–8. doi:10.1093/cid/civ490.
   PubMedGoogle Scholar
• Tiffay K, Jodar L, Kieny MP, Socquet M, LaForce FM. The Evolution of the Meningitis Vaccine Project. Clin Infect Dis. 2015;61(Suppl 5):S396–403. doi:10.1093/cid/civ594.
   PubMedGoogle Scholar
• Aguado MT, Jodar L, Granoff D, Rabinovich R, Ceccarini C, Perkin GW. From Epidemic Meningitis Vaccines for Africa to the Meningitis Vaccine Project. Clin Infect Dis. 2015;61(Suppl 5):S391–5. doi:10.1093/cid/civ593.
   PubMedGoogle Scholar
• Frasch CE, Kapre SV, Lee CH, Preaud JM. Technical Development of a New Meningococcal Conjugate Vaccine. Clin Infect Dis. 2015;61(Suppl 5):S404–9. doi:10.1093/cid/civ595.
   PubMed Web of Science ®Google Scholar
• Djingarey MH, Diomande FV, Barry R, Kandolo D, Shirehwa F, Lingani C, Novak RT, Tevi-Benissan C, Perea W, Preziosi MP, et al. Introduction and Rollout of a New Group A Meningococcal Conjugate Vaccine (PsA-TT) in African Meningitis Belt Countries, 2010–2014. Clin Infect Dis. 2015;61(Suppl 5):S434–41. doi:10.1093/cid/civ551.
   PubMedGoogle Scholar
• Novak RT, Kambou JL, Diomandé FVK, Tarbangdo TF, Ouédraogo-Traoré R, Sangaré L. Serogroup A meningococcal conjugate vaccination in Burkina Faso: Analysis of national surveillance data. Lancet Infectious Diseases. 2012;12:757–64. doi:10.1016/S1473-3099(12)70168-8.
   PubMed Web of Science ®Google Scholar
• Lingani C, Bergeron-Caron C, Stuart JM, Fernandez K, Djingarey MH, Ronveaux O, Schnitzler JC, Perea WA. Meningococcal Meningitis Surveillance in the African Meningitis Belt, 2004–2013. Clin Infect Dis. 2015;61(Suppl 5):S410–5. doi:10.1093/cid/civ597.
   PubMed Web of Science ®Google Scholar
• Daugla D, Gami J, Gamougam K, Naibei N, Mbainadji L, Narbe M, Toralta J, Kodbesse B, Ngadoua C, Coldiron ME. Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: A community trial. Lancet. 2013;383:40–7.
   PubMed Web of Science ®Google Scholar
• Trotter CL, Lingani C, Fernandez K, Cooper LV, Bita A, Tevi-Benissan C, Ronveaux O, Préziosi MP, Stuart JM. Impact of MenAfriVac in nine countries of the African meningitis belt, 2010–15: An analysis of surveillance data. Lancet Infect Dis. 2017;17(8):867–72. doi:10.1016/S1473-3099(17)30301-8.
   PubMed Web of Science ®Google Scholar
• Kristiansen PA, Diomande F, Ba AK, Sanou I, Ouedraogo AS, Ouedraogo R, Sangaré L, Kandolo D, Aké F, Saga IM. Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity. Clin Infect Dis. 2013;56(3):354–63. doi:10.1093/cid/cis892.
   PubMed Web of Science ®Google Scholar
• Kristiansen PA, Ba AK, Ouedraogo AS, Sanou I, Ouedraogo R, Sangare L, Diomandé F, Kandolo D, Saga IM, Misegades L. Persistent low carriage of serogroup A Neisseria meningitidis two years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac. BMC Infect Dis. 2014;14:663. doi:10.1186/s12879-014-0663-4.
   PubMed Web of Science ®Google Scholar
• Berlier M, Barry R, Shadid J, Sirica C, Brunier A, Hasan H, Bouma E. Communication Challenges During the Development and Introduction of a New Meningococcal Vaccine in Africa. Clin Infect Dis. 2015;61(Suppl 5):S451–8. doi:10.1093/cid/civ493.
   PubMedGoogle Scholar
• Funk A, Uadiale K, Kamau C, Caugant DA, Ango U, Greig J. Sequential outbreaks due to a new strain of Neisseria meningitidis serogroup C in northern Nigeria, 2013–14. PLoS currents. 2014;6:pii. doi:10.1371/currents.outbreaks.b50c2aaf1032b3ccade0fca0b63ee518.
   PubMedGoogle Scholar
• Chow J, Uadiale K, Bestman A, Kamau C, Caugant DA, Shehu A, Greig J. Invasive Meningococcal Meningitis Serogroup C Outbreak in Northwest Nigeria, 2015 – Third Consecutive Outbreak of a New Strain. PLoS currents. 2016;8:pii. doi:10.1371/currents.outbreaks.06d10b6b4e690917d8b0a04268906143.
   PubMedGoogle Scholar
• Sidikou F, Zaneidou M, Alkassoum I, Schwartz S, Issaka B, Obama R, Lingani C, Tate A, Ake F, Sakande S. Emergence of epidemic Neisseria meningitidis serogroup C in Niger, 2015: An analysis of national surveillance data. Lancet Infect Dis. 2016;16:1288–94. doi:10.1016/S1473-3099(16)30253-5.
   PubMed Web of Science ®Google Scholar
• WHO. Preparedness for outbreaks of meningococcal meningitis due to Neisseria meningitidis serogroup C in Africa: Recommendations from a WHO expert consultation. Wkly Epidemiol Rec. 2015;90(47):633–6.
   PubMedGoogle Scholar
• WHO. Continuing risk of meningitis due to Neisseria meningitidis serogroup C in Africa: Revised recommendations from a WHO expert consultation. Wkly Epidemiol Rec. 2017;92(41):612–7.
   PubMedGoogle Scholar
• Karachaliou A, Conlan AJ, Preziosi MP, Trotter CL. Modeling Long-term Vaccination Strategies With MenAfriVac in the African Meningitis Belt. Clin Infect Dis. 2015;61(Suppl 5):S594–600. doi:10.1093/cid/civ508.
   PubMed Web of Science ®Google Scholar
• MRF. A global vision for meningitis by 2030 and how to get there. Wilton Park, UK; 2017. https://www.wiltonpark.org.uk/wp-content/uploads/WP1521-Report.pdf.
   Google Scholar